1151 PHARMACEUTICAL DOSAGE FORMS
International Council for Harmonisation (ICH) Guidance Q6A (available at www.ich.org) recommends specifications (list of tests, references to analytical procedures, and acceptance criteria) to ensure that drug products are safe and effective …
Download 1151 PHARMACEUTICAL DOSAGE FORMS
Information
Domain:
Source:
Link to this page:
Documents from same domain
USP <51> Antimicrobial Effectiveness Testing
latam-edu.usp.orgIf the diluted product exhibits antimicrobial properties, specific neutralizers may need to be incorporated into the diluents or the recovery media. The ability of the procedure to measure preservative efficacy may be compromised if the method suitability requires significant dilution (10 −2 or 10 −3) as this will affect the measured recovery
1664 〉〉〉〉 ASSESSMENT OF DRUG PRODUCT …
latam-edu.usp.orgadministration ports, overwraps, adminstration accessories, labels, cardboard boxes, and shrink wrap. A Primary Packaging Component is in direct contact or may come into direct contact with the product (e.g., IV bag). A Secondary Packaging Component is in direct contact with a primary packaging component and may provide additional protection
659 PACKAGING AND STORAGE REQUIREMENTS
latam-edu.usp.orgAncillary component:A component or entity that may come into contact with a Tertiary packaging component during the distribution, storage, and/or transportation of the packaged article (e.g., pallets, skids, and shrink wrap).
Module 08 USP 1115 Bioburden Control of Non-Sterile …
latam-edu.usp.orgUnlike aseptic processing for which facility requirements are generally uniform in specification and performance, nonsterile product manufacturing environments typically involve diverse products and microbial contamination control requirements. In general, liquid, cream, or ointment products require a greater level of
USP <71> Sterility Tests - United States Pharmacopeia
latam-edu.usp.orgThe view from USP <1211> Sterilization and Sterility Assurance of Compendial Articles : 6 ... For products containing a mercurial preservative that cannot be tested by the ... Used for sterility testing of viscous products and for devices having tubes with small lumen.
1117 MICROBIOLOGICAL BEST LABORATORY PRACTICES
latam-edu.usp.orgWhenever possible, sampling equipment should be loaded with its microbiological recovery media in the environment that is to be sampled. All testing in laboratories used for critical testing procedures, such as sterility testing of final dosage forms, bulk product, seed
71 〉〉〉〉 STERILITY TESTS
latam-edu.usp.orgof the test. Modify the conditions in order to eliminate the antimicrobial activity, and repeat the Method Suitability Test. This method suitability is performed (a) when the test for sterility has to be carried out on a new product; and (b) whenever there is a change in the experimental conditions of the test.
1092 THE DISSOLUTION PROCEDURE: DEVELOPMENT AND …
latam-edu.usp.org5.4 Precision 5.4.1 Repeatability of Analysis 5.4.2 Intermediate Precision/Ruggedness 5.4.3 Reproducibility 5.5 Robustness 5.6 Stability of Standard and Sample Solutions ... (such as dynamic solubility, potentiometric titration, or turbidity measurement methods). (USP …
STERILIZATION OF COMPENDIAL ARTICLES
latam-edu.usp.orgFor steam and dry heat, the D-value is a function of temperature. In gas sterilization (ethylene oxide, ClO , or O ), D-values are a function of the chemical concentration, relative humidity, and temperature. Similarly, for liquid chemical sterilization the D-value is a function of the temperature and sterilant concentration.
660 〉〉 CONTAINERS—GLASS
latam-edu.usp.orgglass containers will raise the hydrolytic resistance from a moderate to a high level, changing the classification of the glass to Type II. The following recommendations can be made as to the suitability of the glass type for containers for pharmaceutical products, based on the tests for hydrolytic resistance.
Related documents
MÉTHODES PHARMACOPÉES
univ.ency-education.commatière première) ou le producteur (cas de produit fini) selon les directives du guideline ICH Q6A et les chapitres généraux de la Pharmacopée Européenne Substances pour usage pharmaceutique et ceux sous Formes pharmaceutiques. PHARMACOPÉES Les Pharmacopées sont des recueils réglementaires régulièrement mis à jour et destinés :
ICH GUIDELINES INTRODUCTION, ORGANIZATION & …
www.jiwaji.eduA. SPECIFICATIONS -TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR NEW DRUG SUBSTANCES AND NEW DRUG PRODUCTS:-Main objective of this guideline is to establish a single set of global specifications for new drug substances & drug products.-This guideline addresses specifications, i.e., those tests, procedures, and
ICH HARMONISED TRIPARTITE GUIDELINE
database.ich.orgguideline addresses specifications, i.e., those tests, procedures, and acceptance criteria which play a major role in assuring the quality of the new drug substance and new drug product at release and during shelf life.
Q8(R2) - ICH
database.ich.orgexample, the ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances describes some of the circumstances in which drug product studies are recommended (e.g., Decision
Q 3 B (R2) Impurities in New Drug Products
www.ema.europa.euICH Q6A guideline on specifications). Impurities arising from excipients present in the new drug product or extracted or leached from the container closure system are not covered by this guideline. This guideline also does not apply to new drug products used during the clinical research stages of development. The
Q8 (R2) Step 5 Pharmaceutical Development
www.ema.europa.euThis guideline is intended to provide guidance on the contents of Section 3.2.P.2 (Pharmaceutical Development) for drug products as defined in the scope of Module 3 of the Common Technical Document (ICH guideline M4). The guideline does not apply to contents of submissions for drug products during the clinical research stages of drug development.